發(fā)布時間：2018-11-21 21:07

【摘要】：目的：比較浸潤性膀胱癌術(shù)中放療，和傳統(tǒng)的膀胱部分切除術(shù)與根治性全膀胱切除術(shù)的臨床治療效果。 方法：回顧性分析114例原發(fā)性浸潤性膀胱癌患者的臨床資料，并根據(jù)治療方式將其分為3組：部分切除組（A組，n=36），，術(shù)中放療組（B組，n=35），以及根治組（C組，n=43）。分別對B組與A組，B組與C組兩組患者的年齡，性別，腫瘤的臨床分期，病理分級，手術(shù)時間、術(shù)中出血量、住院天數(shù)、術(shù)后腫瘤復(fù)發(fā)情況以及五年生存率進行統(tǒng)計分析。采用SPSS19.0統(tǒng)計軟件進行處理，計量資料采用均數(shù)±標準差表示，計量資料采取t檢驗，計數(shù)資料采取X2檢驗，以P0.05為差異有統(tǒng)計學(xué)意義。 結(jié)果：3組手術(shù)均成功完成。在A組與B組比較中，在性別、年齡、臨床分期、病理分級、術(shù)中出血量，住院天數(shù)方面，差異無統(tǒng)計學(xué)意義（P0.05），在手術(shù)時間，腫瘤復(fù)發(fā)及五年生存率方面，差異有統(tǒng)計學(xué)意義（P0.05）；在C組與B組中，在性別、年齡、臨床分期、病理分級、腫瘤復(fù)發(fā)及五年生存率方面，差異無統(tǒng)計學(xué)意義（P0.05），在手術(shù)時間，術(shù)中出血量，住院天數(shù)方面，差異有統(tǒng)計學(xué)意義（P0.05）。 結(jié)論：本實驗術(shù)中放療組治療浸潤性膀胱癌的腫瘤復(fù)發(fā)率及五年生存率均與根治組相近，明顯優(yōu)于膀胱部分切除組，而手術(shù)創(chuàng)傷及術(shù)后恢復(fù)情況卻與膀胱部分切除術(shù)相似，是浸潤性膀胱癌是除根治術(shù)外又一項可行的治療方式。
[Abstract]:Objective: to compare the clinical effects of intraoperative radiotherapy for invasive bladder cancer and traditional partial cystectomy and radical total cystectomy. Methods: the clinical data of 114 patients with primary invasive bladder cancer were retrospectively analyzed and divided into 3 groups according to the treatment methods: partial resection group (group A, n = 36), intraoperative radiotherapy group (group B, n = 35) and radical resection group (group C, n = 43). The age, sex, clinical stage, pathological grade, operative time, intraoperative bleeding volume, hospital stay, recurrence of tumor and 5-year survival rate were statistically analyzed in group B and group A, group B and group C respectively. SPSS19.0 statistical software was used to process the measurement data with mean 鹵standard deviation, measurement data with t test, count data with X2 test, with P0.05 as the difference was statistically significant. Results: all the 3 groups were successfully completed. There was no significant difference between group A and group B in sex, age, clinical stage, pathological grade, intraoperative bleeding volume and length of hospitalization (P0.05), but there was no significant difference in operative time, tumor recurrence and 5-year survival rate. The difference was statistically significant (P0.05). In group C and group B, there was no significant difference in sex, age, clinical stage, pathological grade, tumor recurrence and 5-year survival rate (P0.05). The difference was statistically significant (P0.05). Conclusion: the tumor recurrence rate and 5-year survival rate in the intraoperative radiotherapy group were similar to those in the radical resection group, and were significantly superior to those in the partial cystectomy group, but the surgical trauma and postoperative recovery were similar to those in the cystectomy group. Invasive bladder cancer is a feasible treatment in addition to radical resection.
【學(xué)位授予單位】：蘇州大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2014
【分類號】：R737.14

【參考文獻】

相關(guān)期刊論文 前6條

1 張振聲;蔡小兵;許傳亮;鄧震;吳承耀;唐亮;王海峰;陳俊毅;王洋;曾欽松;徐偉東;孫穎浩;;“超聲膀胱軟鏡”可輔助用于初發(fā)膀胱腫瘤術(shù)前分期診斷[J];第二軍醫(yī)大學(xué)學(xué)報;2011年06期

2 薛圣留;晚期膀胱癌的化療進展[J];國外醫(yī)學(xué).泌尿系統(tǒng)分冊;2004年03期

3 韓蘇軍;張思維;陳萬青;李長嶺;;中國膀胱癌發(fā)病現(xiàn)狀及流行趨勢分析[J];癌癥進展;2013年01期

4 夏溟,臧美孚,李漢忠,畢文芳,尹松年;中國職業(yè)性膀胱癌的生物學(xué)監(jiān)測及其意義[J];中華泌尿外科雜志;2003年10期

5 李鳴,李寧忱,黃真,那彥群;浸潤性膀胱癌術(shù)前選擇性髂內(nèi)動脈灌注化療的近遠期療效觀察[J];中華泌尿外科雜志;2004年10期

6 姜帥;王國民;孫立安;張立;徐志兵;林宗明;戎瑞明;郭劍明;;鈥激光與等離子電切治療非肌層浸潤性膀胱尿路上皮癌的前瞻性隨機對照研究[J];中國微創(chuàng)外科雜志;2012年11期

本文編號：2348259